Work

Abstract PS1-12-30: Real-world outcomes of first-line cdk4/6 inhibitor use in hr+/her2− metastatic breast cancer: a single-institution experience

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-12-30

Authors: F. T. FAQIHI, M. F. ALDAWOUD, N. ALGAZLAN, A. A. ALMAZYAD, A. R. ALTAMIMI, M. RUDAINEE, M. M. ALHARBI, A. A. ALWOHAIBI, A. K. ALTWAIRGI

Institution: King Fahd Medical City

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129460926

Cites:

Cited by:

Related to: